Revance Therapeutics: Q2 Earnings Insights

Revance Therapeutics RVNC reported its Q2 earnings results on Tuesday, August 9, 2022 at 04:00 PM.

Here's what investors need to know about the announcement.

Earnings

Revance Therapeutics missed estimated earnings by 2.33%, reporting an EPS of $-0.88 versus an estimate of $-0.86.

Revenue was up $9.56 million from the same period last year.

Past Earnings Performance

Last quarter the company missed on EPS by $0.03 which was followed by a 11.04% drop in the share price the next day.

Here's a look at Revance Therapeutics's past performance:

To track all earnings releases for Revance Therapeutics visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.